Computer algorithm for ATTR
2000026611
Phase 1 other terminated
Quick answer
Computer algorithm for ATTR for Transthyretin Amyloidosis is a Phase 1 program (other) at ALNYLAM PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ALNYLAM PHARMACEUTICALS, INC.
- Indication
- Transthyretin Amyloidosis
- Phase
- Phase 1
- Modality
- other
- Status
- terminated